Johnson & Johnson said Thursday it will invest $2 billion in North Carolina to expand U.S. manufacturing, according to Reuters. The move comes as Trump’s proposed drug import tariffs are pressuring global pharma firms. The company signed a 10-year deal with Fujifilm Diosynth for its 160,000-square-foot Holly Springs site, expected to create 120 jobs. J&J also plans further U.S. facilities and expansions in the coming months. The move follows its March pledge to raise U.S. investments by 25% to more than $55 billion over four years, including a new plant in Wilson, North Carolina. Other major drugmakers such as Eli Lilly and AstraZeneca have also boosted U.S. spending in response to Trump’s tariff threats.
Be the first to comment